ETON offering history
Every offering-related filing in Eton Pharmaceuticals, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 403 filings back to Jun 28, 2017.
| Date | Filing | What it means | |
|---|---|---|---|
| Dec 12, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Apr 18, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| May 2, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 7, 2023 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Apr 9, 2021 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Apr 7, 2021 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Oct 15, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Oct 13, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 25, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jul 31, 2020 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Mar 30, 2020 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Mar 30, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Dec 16, 2019 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Dec 2, 2019 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Nov 13, 2018 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Nov 9, 2018 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Nov 5, 2018 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Oct 31, 2018 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Oct 18, 2018 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Sep 28, 2018 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Sep 25, 2018 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Aug 10, 2018 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
ETON offering FAQ
When did ETON last execute an offering?
Per SEC filings, Eton Pharmaceuticals, Inc.'s most recent priced offering document is a 424B5 filed 2024-12-12. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did ETON last announce or register an offering?
The most recent registration is a S-3 filed 2023-04-07. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.